nodes	percent_of_prediction	percent_of_DWPC	metapath
Fluoxymesterone—SHBG—semen—cervical cancer	0.0771	0.108	CbGeAlD
Fluoxymesterone—PRLR—uterine cervix—cervical cancer	0.0652	0.0918	CbGeAlD
Fluoxymesterone—PRLR—decidua—cervical cancer	0.0621	0.0874	CbGeAlD
Fluoxymesterone—PRLR—endometrium—cervical cancer	0.059	0.083	CbGeAlD
Fluoxymesterone—AR—semen—cervical cancer	0.0553	0.0779	CbGeAlD
Fluoxymesterone—PRLR—uterus—cervical cancer	0.0543	0.0765	CbGeAlD
Fluoxymesterone—PRLR—female gonad—cervical cancer	0.0444	0.0626	CbGeAlD
Fluoxymesterone—SHBG—endometrium—cervical cancer	0.0127	0.0179	CbGeAlD
Fluoxymesterone—PRLR—Growth hormone receptor signaling—STAT3—cervical cancer	0.0124	0.0429	CbGpPWpGaD
Fluoxymesterone—AR—Notch-mediated HES/HEY network—YY1—cervical cancer	0.0119	0.041	CbGpPWpGaD
Fluoxymesterone—SHBG—uterus—cervical cancer	0.0117	0.0165	CbGeAlD
Fluoxymesterone—AR—Coregulation of Androgen receptor activity—PIAS3—cervical cancer	0.0115	0.0397	CbGpPWpGaD
Fluoxymesterone—SHBG—female reproductive system—cervical cancer	0.0105	0.0148	CbGeAlD
Fluoxymesterone—AR—epithelium—cervical cancer	0.0102	0.0143	CbGeAlD
Fluoxymesterone—AR—uterine cervix—cervical cancer	0.0101	0.0142	CbGeAlD
Fluoxymesterone—ESR1—epithelium—cervical cancer	0.01	0.0141	CbGeAlD
Fluoxymesterone—ESR1—uterine cervix—cervical cancer	0.00992	0.014	CbGeAlD
Fluoxymesterone—AR—decidua—cervical cancer	0.00962	0.0135	CbGeAlD
Fluoxymesterone—SHBG—female gonad—cervical cancer	0.0096	0.0135	CbGeAlD
Fluoxymesterone—SHBG—vagina—cervical cancer	0.00954	0.0134	CbGeAlD
Fluoxymesterone—AR—renal system—cervical cancer	0.00945	0.0133	CbGeAlD
Fluoxymesterone—ESR1—decidua—cervical cancer	0.00945	0.0133	CbGeAlD
Fluoxymesterone—ESR1—renal system—cervical cancer	0.00928	0.0131	CbGeAlD
Fluoxymesterone—AR—Regulation of nuclear SMAD2/3 signaling—PIAS3—cervical cancer	0.00916	0.0316	CbGpPWpGaD
Fluoxymesterone—AR—endometrium—cervical cancer	0.00914	0.0129	CbGeAlD
Fluoxymesterone—ESR1—endometrium—cervical cancer	0.00897	0.0126	CbGeAlD
Fluoxymesterone—AR—mammalian vulva—cervical cancer	0.00884	0.0124	CbGeAlD
Fluoxymesterone—AR—Nuclear Receptors—RARB—cervical cancer	0.00882	0.0305	CbGpPWpGaD
Fluoxymesterone—ESR1—Validated nuclear estrogen receptor alpha network—POU4F1—cervical cancer	0.00852	0.0294	CbGpPWpGaD
Fluoxymesterone—AR—Androgen receptor signaling pathway—PIAS3—cervical cancer	0.0085	0.0294	CbGpPWpGaD
Fluoxymesterone—AR—uterus—cervical cancer	0.00842	0.0119	CbGeAlD
Fluoxymesterone—ESR1—uterus—cervical cancer	0.00827	0.0116	CbGeAlD
Fluoxymesterone—AR—female reproductive system—cervical cancer	0.00757	0.0107	CbGeAlD
Fluoxymesterone—ESR1—female reproductive system—cervical cancer	0.00743	0.0105	CbGeAlD
Fluoxymesterone—AR—Coregulation of Androgen receptor activity—UBE3A—cervical cancer	0.00741	0.0256	CbGpPWpGaD
Fluoxymesterone—NR3C1—epithelium—cervical cancer	0.00738	0.0104	CbGeAlD
Fluoxymesterone—NR3C1—uterine cervix—cervical cancer	0.00732	0.0103	CbGeAlD
Fluoxymesterone—ESR1—Regulation of nuclear SMAD2/3 signaling—PIAS3—cervical cancer	0.00706	0.0244	CbGpPWpGaD
Fluoxymesterone—NR3C1—decidua—cervical cancer	0.00697	0.00981	CbGeAlD
Fluoxymesterone—AR—Nuclear Receptor transcription pathway—RARB—cervical cancer	0.00697	0.0241	CbGpPWpGaD
Fluoxymesterone—NR3C1—Regulation of nuclear SMAD2/3 signaling—PIAS3—cervical cancer	0.00695	0.024	CbGpPWpGaD
Fluoxymesterone—AR—female gonad—cervical cancer	0.00689	0.00969	CbGeAlD
Fluoxymesterone—AR—vagina—cervical cancer	0.00685	0.00964	CbGeAlD
Fluoxymesterone—NR3C1—renal system—cervical cancer	0.00684	0.00963	CbGeAlD
Fluoxymesterone—ESR1—Nuclear Receptors—RARB—cervical cancer	0.00679	0.0235	CbGpPWpGaD
Fluoxymesterone—ESR1—female gonad—cervical cancer	0.00676	0.00952	CbGeAlD
Fluoxymesterone—ESR1—vagina—cervical cancer	0.00672	0.00946	CbGeAlD
Fluoxymesterone—NR3C1—Nuclear Receptors—RARB—cervical cancer	0.00669	0.0231	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling events mediated by PTP1B—STAT3—cervical cancer	0.00668	0.0231	CbGpPWpGaD
Fluoxymesterone—NR3C1—endometrium—cervical cancer	0.00662	0.00931	CbGeAlD
Fluoxymesterone—NR3C1—mammalian vulva—cervical cancer	0.0064	0.00901	CbGeAlD
Fluoxymesterone—NR3C1—uterus—cervical cancer	0.0061	0.00858	CbGeAlD
Fluoxymesterone—PRLR—Signaling events mediated by PTP1B—EGFR—cervical cancer	0.00608	0.021	CbGpPWpGaD
Fluoxymesterone—NR3C1—female reproductive system—cervical cancer	0.00548	0.00772	CbGeAlD
Fluoxymesterone—AR—Androgen receptor signaling pathway—UBE3A—cervical cancer	0.00548	0.0189	CbGpPWpGaD
Fluoxymesterone—ESR1—Nuclear Receptor transcription pathway—RARB—cervical cancer	0.00537	0.0185	CbGpPWpGaD
Fluoxymesterone—PRLR—Cytokine Signaling in Immune system—HLA-DPB1—cervical cancer	0.00536	0.0185	CbGpPWpGaD
Fluoxymesterone—NR3C1—Nuclear Receptor transcription pathway—RARB—cervical cancer	0.00529	0.0183	CbGpPWpGaD
Fluoxymesterone—ESR1—Regulation of Telomerase—UBE3A—cervical cancer	0.00523	0.0181	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling by ERBB4—FGFR3—cervical cancer	0.00521	0.018	CbGpPWpGaD
Fluoxymesterone—NR3C1—female gonad—cervical cancer	0.00499	0.00702	CbGeAlD
Fluoxymesterone—NR3C1—vagina—cervical cancer	0.00496	0.00698	CbGeAlD
Fluoxymesterone—AR—lymph node—cervical cancer	0.00443	0.00623	CbGeAlD
Fluoxymesterone—ESR1—lymph node—cervical cancer	0.00435	0.00612	CbGeAlD
Fluoxymesterone—PRLR—Cytokine Signaling in Immune system—HLA-DQB1—cervical cancer	0.00419	0.0145	CbGpPWpGaD
Fluoxymesterone—AR—Notch-mediated HES/HEY network—HES1—cervical cancer	0.00404	0.014	CbGpPWpGaD
Fluoxymesterone—ESR1—Estrogen Receptor Pathway—STAT3—cervical cancer	0.0038	0.0131	CbGpPWpGaD
Fluoxymesterone—PRLR—Adipogenesis—CTNNB1—cervical cancer	0.00368	0.0127	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling by ERBB4—MTOR—cervical cancer	0.00367	0.0127	CbGpPWpGaD
Fluoxymesterone—PRLR—Adipogenesis—STAT3—cervical cancer	0.00321	0.0111	CbGpPWpGaD
Fluoxymesterone—NR3C1—lymph node—cervical cancer	0.00321	0.00451	CbGeAlD
Fluoxymesterone—AR—Notch-mediated HES/HEY network—NOTCH1—cervical cancer	0.00305	0.0105	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—UBE3A—cervical cancer	0.00293	0.0101	CbGpPWpGaD
Fluoxymesterone—ESR1—ATF-2 transcription factor network—HES1—cervical cancer	0.0026	0.00896	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling by ERBB4—EGFR—cervical cancer	0.00258	0.0089	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—TAAR6—cervical cancer	0.00247	0.00852	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—RARB—cervical cancer	0.00242	0.00837	CbGpPWpGaD
Fluoxymesterone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—TERT—cervical cancer	0.00231	0.00799	CbGpPWpGaD
Fluoxymesterone—AR—Notch-mediated HES/HEY network—CD4—cervical cancer	0.00228	0.00788	CbGpPWpGaD
Fluoxymesterone—AR—Coregulation of Androgen receptor activity—CASP8—cervical cancer	0.00226	0.00779	CbGpPWpGaD
Fluoxymesterone—ESR1—Regulation of Telomerase—TERT—cervical cancer	0.00203	0.00701	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—WNT2—cervical cancer	0.00193	0.00665	CbGpPWpGaD
Fluoxymesterone—ESR1—LKB1 signaling events—MTOR—cervical cancer	0.00189	0.00653	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—RARB—cervical cancer	0.00187	0.00645	CbGpPWpGaD
Fluoxymesterone—AR—Notch-mediated HES/HEY network—STAT3—cervical cancer	0.00177	0.0061	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—HLA-DPB1—cervical cancer	0.00175	0.00605	CbGpPWpGaD
Fluoxymesterone—PRLR—Cytokine Signaling in Immune system—STAT3—cervical cancer	0.00174	0.006	CbGpPWpGaD
Fluoxymesterone—NR3C1—Endoderm Differentiation—NOTCH1—cervical cancer	0.00172	0.00595	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—AKAP13—cervical cancer	0.00169	0.00584	CbGpPWpGaD
Fluoxymesterone—AR—Coregulation of Androgen receptor activity—CTNNB1—cervical cancer	0.00165	0.00568	CbGpPWpGaD
Fluoxymesterone—AR—SIDS Susceptibility Pathways—HES1—cervical cancer	0.00155	0.00535	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—WNT5A—cervical cancer	0.00146	0.00504	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—HLA-DQB1—cervical cancer	0.00137	0.00472	CbGpPWpGaD
Fluoxymesterone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CTNNB1—cervical cancer	0.00132	0.00457	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling mediated by p38-alpha and p38-beta—TP53—cervical cancer	0.00131	0.00454	CbGpPWpGaD
Fluoxymesterone—ESR1—Regulation of Telomerase—MTOR—cervical cancer	0.00131	0.00453	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—CD8A—cervical cancer	0.00128	0.00441	CbGpPWpGaD
Fluoxymesterone—ESR1—Aryl Hydrocarbon Receptor—EGFR—cervical cancer	0.00126	0.00435	CbGpPWpGaD
Fluoxymesterone—AR—Androgen receptor signaling pathway—CTNNB1—cervical cancer	0.00122	0.0042	CbGpPWpGaD
Fluoxymesterone—ESR1—Leptin signaling pathway—MTOR—cervical cancer	0.00121	0.00418	CbGpPWpGaD
Fluoxymesterone—AR—Generic Transcription Pathway—RARB—cervical cancer	0.0012	0.00416	CbGpPWpGaD
Fluoxymesterone—NR3C1—SIDS Susceptibility Pathways—HES1—cervical cancer	0.00117	0.00406	CbGpPWpGaD
Fluoxymesterone—NR3C1—Endoderm Differentiation—CTNNB1—cervical cancer	0.00114	0.00395	CbGpPWpGaD
Fluoxymesterone—ESR1—AP-1 transcription factor network—CTNNB1—cervical cancer	0.00114	0.00392	CbGpPWpGaD
Fluoxymesterone—NR3C1—AP-1 transcription factor network—CTNNB1—cervical cancer	0.00112	0.00386	CbGpPWpGaD
Fluoxymesterone—ESR1—LKB1 signaling events—TP53—cervical cancer	0.00112	0.00385	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Breast Cancer Pathway—CASP8—cervical cancer	0.00109	0.00377	CbGpPWpGaD
Fluoxymesterone—AR—Androgen receptor signaling pathway—STAT3—cervical cancer	0.00106	0.00366	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—FGFR3—cervical cancer	0.00104	0.00361	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—NOTCH2—cervical cancer	0.00102	0.00354	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling by ERBB4—FGFR3—cervical cancer	0.000979	0.00338	CbGpPWpGaD
Fluoxymesterone—AR—Androgen receptor signaling pathway—EGFR—cervical cancer	0.000963	0.00333	CbGpPWpGaD
Fluoxymesterone—ESR1—Leptin signaling pathway—STAT3—cervical cancer	0.000936	0.00323	CbGpPWpGaD
Fluoxymesterone—ESR1—Generic Transcription Pathway—RARB—cervical cancer	0.000927	0.0032	CbGpPWpGaD
Fluoxymesterone—ESR1—Regulation of Telomerase—EGFR—cervical cancer	0.00092	0.00318	CbGpPWpGaD
Fluoxymesterone—NR3C1—Generic Transcription Pathway—RARB—cervical cancer	0.000913	0.00315	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—CASP8—cervical cancer	0.000905	0.00313	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Breast Cancer Pathway—MTOR—cervical cancer	0.000899	0.0031	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—CASP8—cervical cancer	0.000893	0.00308	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Breast Cancer Pathway—CASP8—cervical cancer	0.000841	0.00291	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—HES1—cervical cancer	0.00084	0.0029	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Breast Cancer Pathway—CASP3—cervical cancer	0.000827	0.00285	CbGpPWpGaD
Fluoxymesterone—AR—SIDS Susceptibility Pathways—CASP3—cervical cancer	0.000805	0.00278	CbGpPWpGaD
Fluoxymesterone—AR—Generic Transcription Pathway—NOTCH2—cervical cancer	0.000797	0.00275	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Breast Cancer Pathway—CTNNB1—cervical cancer	0.000797	0.00275	CbGpPWpGaD
Fluoxymesterone—AR—SIDS Susceptibility Pathways—CTNNB1—cervical cancer	0.000776	0.00268	CbGpPWpGaD
Fluoxymesterone—ESR1—AP-1 transcription factor network—TP53—cervical cancer	0.000755	0.00261	CbGpPWpGaD
Fluoxymesterone—NR3C1—AP-1 transcription factor network—TP53—cervical cancer	0.000744	0.00257	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—TERT—cervical cancer	0.000736	0.00254	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—MTOR—cervical cancer	0.000735	0.00254	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—CD4—cervical cancer	0.000733	0.00253	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—CASP8—cervical cancer	0.000697	0.00241	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Breast Cancer Pathway—MTOR—cervical cancer	0.000692	0.00239	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling by ERBB4—MTOR—cervical cancer	0.000689	0.00238	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—CASP3—cervical cancer	0.000685	0.00237	CbGpPWpGaD
Fluoxymesterone—NR3C1—Adipogenesis—CTNNB1—cervical cancer	0.000681	0.00235	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—FGFR3—cervical cancer	0.000675	0.00233	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—CTNNB1—cervical cancer	0.00066	0.00228	CbGpPWpGaD
Fluoxymesterone—NR3C1—Glucocorticoid receptor regulatory network—TP53—cervical cancer	0.000655	0.00226	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—CTNNB1—cervical cancer	0.000651	0.00225	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Breast Cancer Pathway—CASP3—cervical cancer	0.000637	0.0022	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—NOTCH1—cervical cancer	0.000634	0.00219	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Breast Cancer Pathway—EGFR—cervical cancer	0.000631	0.00218	CbGpPWpGaD
Fluoxymesterone—ESR1—Generic Transcription Pathway—NOTCH2—cervical cancer	0.000614	0.00212	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Breast Cancer Pathway—CTNNB1—cervical cancer	0.000614	0.00212	CbGpPWpGaD
Fluoxymesterone—NR3C1—SIDS Susceptibility Pathways—CASP3—cervical cancer	0.000611	0.00211	CbGpPWpGaD
Fluoxymesterone—NR3C1—Generic Transcription Pathway—NOTCH2—cervical cancer	0.000605	0.00209	CbGpPWpGaD
Fluoxymesterone—NR3C1—Adipogenesis—STAT3—cervical cancer	0.000594	0.00205	CbGpPWpGaD
Fluoxymesterone—NR3C1—SIDS Susceptibility Pathways—CTNNB1—cervical cancer	0.000589	0.00203	CbGpPWpGaD
Fluoxymesterone—AR—Gene Expression—RARB—cervical cancer	0.00058	0.002	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—STAT3—cervical cancer	0.000568	0.00196	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Breast Cancer Pathway—TP53—cervical cancer	0.00053	0.00183	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—CASP3—cervical cancer	0.000528	0.00182	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—EGFR—cervical cancer	0.000523	0.00181	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—EGFR—cervical cancer	0.000516	0.00178	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—CTNNB1—cervical cancer	0.000509	0.00176	CbGpPWpGaD
Fluoxymesterone—AR—Generic Transcription Pathway—NOTCH1—cervical cancer	0.000494	0.0017	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Breast Cancer Pathway—EGFR—cervical cancer	0.000486	0.00168	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling by ERBB4—EGFR—cervical cancer	0.000484	0.00167	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—MTOR—cervical cancer	0.000475	0.00164	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—TAAR6—cervical cancer	0.000463	0.0016	CbGpPWpGaD
Fluoxymesterone—ESR1—Gene Expression—RARB—cervical cancer	0.000446	0.00154	CbGpPWpGaD
Fluoxymesterone—NR3C1—Gene Expression—RARB—cervical cancer	0.00044	0.00152	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—TP53—cervical cancer	0.000439	0.00152	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—CASP3—cervical cancer	0.000437	0.00151	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—CTNNB1—cervical cancer	0.000421	0.00145	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Breast Cancer Pathway—TP53—cervical cancer	0.000408	0.00141	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—EGFR—cervical cancer	0.000403	0.00139	CbGpPWpGaD
Fluoxymesterone—AR—Gene Expression—NOTCH2—cervical cancer	0.000384	0.00133	CbGpPWpGaD
Fluoxymesterone—ESR1—Generic Transcription Pathway—NOTCH1—cervical cancer	0.00038	0.00131	CbGpPWpGaD
Fluoxymesterone—NR3C1—Generic Transcription Pathway—NOTCH1—cervical cancer	0.000374	0.00129	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—STAT3—cervical cancer	0.000367	0.00127	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—WNT2—cervical cancer	0.000362	0.00125	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—TP53—cervical cancer	0.000338	0.00117	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—EGFR—cervical cancer	0.000334	0.00115	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—AKAP13—cervical cancer	0.000317	0.0011	CbGpPWpGaD
Fluoxymesterone—ESR1—Gene Expression—NOTCH2—cervical cancer	0.000296	0.00102	CbGpPWpGaD
Fluoxymesterone—NR3C1—Gene Expression—NOTCH2—cervical cancer	0.000291	0.00101	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—TP53—cervical cancer	0.00028	0.000968	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—WNT5A—cervical cancer	0.000274	0.000946	CbGpPWpGaD
Fluoxymesterone—AR—Gene Expression—NOTCH1—cervical cancer	0.000238	0.000821	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—NOTCH2—cervical cancer	0.000192	0.000664	CbGpPWpGaD
Fluoxymesterone—ESR1—Gene Expression—NOTCH1—cervical cancer	0.000183	0.000632	CbGpPWpGaD
Fluoxymesterone—NR3C1—Gene Expression—NOTCH1—cervical cancer	0.00018	0.000623	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—HES1—cervical cancer	0.000158	0.000545	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—TERT—cervical cancer	0.000138	0.000477	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—FGFR3—cervical cancer	0.000127	0.000438	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—NOTCH1—cervical cancer	0.000119	0.000411	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—MTOR—cervical cancer	8.92e-05	0.000308	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—CASP3—cervical cancer	8.2e-05	0.000283	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—CTNNB1—cervical cancer	7.91e-05	0.000273	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—STAT3—cervical cancer	6.89e-05	0.000238	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—EGFR—cervical cancer	6.26e-05	0.000216	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—TP53—cervical cancer	5.26e-05	0.000182	CbGpPWpGaD
